Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	TBP-class protein binding	NACA NR3C1 NR3C2 TAF1	2.08e-05	33	99	4	GO:0017025
GeneOntologyMolecularFunction	acyl-CoA binding	ACADM PNPLA3 TAF1	2.83e-04	26	99	3	GO:0120227
GeneOntologyMolecularFunction	general transcription initiation factor binding	NACA NR3C1 NR3C2 TAF1	2.88e-04	64	99	4	GO:0140296
GeneOntologyBiologicalProcess	negative regulation of complement activation, classical pathway	CR1 CR2 C4BPA	5.55e-06	8	97	3	GO:0045959
GeneOntologyBiologicalProcess	regulation of complement activation, classical pathway	CR1 CR2 C4BPA	1.18e-05	10	97	3	GO:0030450
GeneOntologyBiologicalProcess	negative regulation of humoral immune response mediated by circulating immunoglobulin	CR1 CR2 C4BPA	2.15e-05	12	97	3	GO:0002924
GeneOntologyBiologicalProcess	negative regulation of complement activation	CR1 CR2 C4BPA	3.53e-05	14	97	3	GO:0045916
GeneOntologyBiologicalProcess	negative regulation of B cell mediated immunity	CR1 CR2 C4BPA	5.40e-05	16	97	3	GO:0002713
GeneOntologyBiologicalProcess	negative regulation of immunoglobulin mediated immune response	CR1 CR2 C4BPA	5.40e-05	16	97	3	GO:0002890
GeneOntologyBiologicalProcess	negative regulation of humoral immune response	CR1 CR2 C4BPA	9.25e-05	19	97	3	GO:0002921
GeneOntologyBiologicalProcess	regulation of humoral immune response mediated by circulating immunoglobulin	CR1 CR2 C4BPA	1.46e-04	22	97	3	GO:0002923
GeneOntologyCellularComponent	postsynaptic density	MAP1B CPEB3 GRIA4 NR3C1 GRIP1 PTPRO NR3C2 CTNND2 EPHA7	3.14e-04	451	100	9	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	MAP1B CPEB3 GRIA4 NR3C1 GRIP1 PTPRO NR3C2 CTNND2 EPHA7	4.72e-04	477	100	9	GO:0032279
GeneOntologyCellularComponent	postsynaptic specialization	MAP1B CPEB3 GRIA4 NR3C1 GRIP1 PTPRO NR3C2 CTNND2 EPHA7	6.90e-04	503	100	9	GO:0099572
GeneOntologyCellularComponent	dendrite	CHL1 DIP2B MAP1B CPEB3 APC GRIA4 NR3C1 GRIP1 PTPRO KCNQ3 CTNND2 EPHA7	8.07e-04	858	100	12	GO:0030425
GeneOntologyCellularComponent	dendritic tree	CHL1 DIP2B MAP1B CPEB3 APC GRIA4 NR3C1 GRIP1 PTPRO KCNQ3 CTNND2 EPHA7	8.23e-04	860	100	12	GO:0097447
GeneOntologyCellularComponent	neuron to neuron synapse	MAP1B CPEB3 GRIA4 NR3C1 GRIP1 PTPRO NR3C2 CTNND2 EPHA7	9.08e-04	523	100	9	GO:0098984
GeneOntologyCellularComponent	lateral plasma membrane	CORO1C APC PTPRO OCLN	9.19e-04	90	100	4	GO:0016328
Domain	Sushi	APOH CR1 CR2 CSMD3 C4BPA	8.06e-06	52	99	5	PF00084
Domain	CCP	APOH CR1 CR2 CSMD3 C4BPA	9.73e-06	54	99	5	SM00032
Domain	SUSHI	APOH CR1 CR2 CSMD3 C4BPA	1.17e-05	56	99	5	PS50923
Domain	Sushi_SCR_CCP_dom	APOH CR1 CR2 CSMD3 C4BPA	1.27e-05	57	99	5	IPR000436
Domain	FN3	CHL1 FLNC COL12A1 TNC PTPRO CNTN3 EPHA7	5.77e-05	185	99	7	SM00060
Domain	AFAP	AFAP1 AFAP1L2	8.32e-05	3	99	2	IPR030113
Domain	FN3_dom	CHL1 FLNC COL12A1 TNC PTPRO CNTN3 EPHA7	1.24e-04	209	99	7	IPR003961
Domain	fn3	CHL1 COL12A1 TNC PTPRO CNTN3 EPHA7	2.24e-04	162	99	6	PF00041
Pubmed	Genetic organization of complement receptor-related genes in the mouse.	CR1 CR2 C4BPA	1.28e-06	8	100	3	2564419
Pubmed	Mixed Lineage Leukemia 5 (MLL5) Protein Stability Is Cooperatively Regulated by O-GlcNac Transferase (OGT) and Ubiquitin Specific Protease 7 (USP7).	KMT2E USP10 CDK11B TOP2A	1.91e-06	31	100	4	26678539
Pubmed	Genome-wide association study of smoking behaviours among Bangladeshi adults.	ZFAT ITPR2 GRIP1 CNTN3	2.79e-06	34	100	4	24665060
Pubmed	Mapping of recombinant retrovirus integration sites that cause expression of the viral genome in murine embryonal carcinoma cells.	CR1 CR2 GUSB	3.74e-06	11	100	3	1543915
Pubmed	Adhesion molecules close homolog of L1 and tenascin-C affect blood-spinal cord barrier repair.	CHL1 TNC	8.18e-06	2	100	2	22473292
Pubmed	MR and GR functional SNPs may modulate tobacco smoking susceptibility.	NR3C1 NR3C2	8.18e-06	2	100	2	23543128
Pubmed	Complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) cooperate in the binding of hydrolyzed complement factor 3 (C3i) to human B lymphocytes.	CR1 CR2	8.18e-06	2	100	2	14635039
Pubmed	Epidermal glucocorticoid and mineralocorticoid receptors act cooperatively to regulate epidermal development and counteract skin inflammation.	NR3C1 NR3C2	8.18e-06	2	100	2	29789551
Pubmed	Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone.	NR3C1 NR3C2	8.18e-06	2	100	2	16361444
Pubmed	Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients.	NR3C1 NR3C2	8.18e-06	2	100	2	23137715
Pubmed	Loss of central mineralocorticoid or glucocorticoid receptors impacts auditory nerve processing in the cochlea.	NR3C1 NR3C2	8.18e-06	2	100	2	35281733
Pubmed	Single nucleotide polymorphism creating a variable upstream open reading frame regulates glucocorticoid receptor expression.	NR3C1 NR3C2	8.18e-06	2	100	2	25771224
Pubmed	No associations of the mineralocorticoid and glucocorticoid receptor genes with asthma.	NR3C1 NR3C2	8.18e-06	2	100	2	23204024
Pubmed	The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells.	CR1 CR2	8.18e-06	2	100	2	11981823
Pubmed	Metaplasticity of amygdalar responses to the stress hormone corticosterone.	NR3C1 NR3C2	8.18e-06	2	100	2	20663957
Pubmed	Cardiomyocyte glucocorticoid and mineralocorticoid receptors directly and antagonistically regulate heart disease in mice.	NR3C1 NR3C2	8.18e-06	2	100	2	30992401
Pubmed	A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal disease.	CPB2 TAF1	8.18e-06	2	100	2	14717966
Pubmed	The role of genetic variation in the glucocorticoid receptor (NR3C1) and mineralocorticoid receptor (NR3C2) in the association between cortisol response and cognition under acute stress.	NR3C1 NR3C2	8.18e-06	2	100	2	29100174
Pubmed	Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice.	NR3C1 NR3C2	8.18e-06	2	100	2	11258486
Pubmed	Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line.	NR3C1 NR3C2	8.18e-06	2	100	2	15743993
Pubmed	The mineralocorticoid receptor may compensate for the loss of the glucocorticoid receptor at specific stages of mammary gland development.	NR3C1 NR3C2	8.18e-06	2	100	2	12198239
Pubmed	Molecular mechanisms of repeated social defeat-induced glucocorticoid resistance: Role of microRNA.	NR3C1 NR3C2	8.18e-06	2	100	2	25317829
Pubmed	PSMD5 Inactivation Promotes 26S Proteasome Assembly during Colorectal Tumor Progression.	APC PSMD5	8.18e-06	2	100	2	29716915
Pubmed	Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.	CR1 CR2	8.18e-06	2	100	2	1708808
Pubmed	Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice.	NR3C1 NR3C2	8.18e-06	2	100	2	17360585
Pubmed	Role of Pro-637 and Gln-642 in human glucocorticoid receptors and Ser-843 and Leu-848 in mineralocorticoid receptors in their differential responses to cortisol and aldosterone.	NR3C1 NR3C2	8.18e-06	2	100	2	26907965
Pubmed	Membrane mineralocorticoid but not glucocorticoid receptors of the dorsal hippocampus mediate the rapid effects of corticosterone on memory retrieval.	NR3C1 NR3C2	8.18e-06	2	100	2	21814189
Pubmed	TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study.	CPB2 TAF1	8.18e-06	2	100	2	15978108
Pubmed	Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris.	CPB2 TAF1	8.18e-06	2	100	2	12876631
Pubmed	Genetic Associations and Interactions Between the NR3C1 (GR) and NR3C2 (MR) Genes and Aggressive Behavior in a Central South Chinese Han Population.	NR3C1 NR3C2	8.18e-06	2	100	2	28686058
Pubmed	Glucocorticoid and mineralocorticoid receptor polymorphisms and recurrence of major depressive disorder.	NR3C1 NR3C2	8.18e-06	2	100	2	25765757
Pubmed	Molecular genetic analysis of glucocorticoid and mineralocorticoid signaling in development and physiological processes.	NR3C1 NR3C2	8.18e-06	2	100	2	8733008
Pubmed	Age-dependent expression of glucocorticoid- and mineralocorticoid receptors on neural precursor cell populations in the adult murine hippocampus.	NR3C1 NR3C2	8.18e-06	2	100	2	15569353
Pubmed	Stimulation of both type I and type II corticosteroid receptors blunts counterregulatory responses to subsequent hypoglycemia in healthy man.	NR3C1 NR3C2	8.18e-06	2	100	2	18182467
Pubmed	Glucocorticoid and mineralocorticoid receptor polymorphisms and clinical characteristics in bipolar disorder patients.	NR3C1 NR3C2	8.18e-06	2	100	2	21531081
Pubmed	Mental performance in old age dependent on cortisol and genetic variance in the mineralocorticoid and glucocorticoid receptors.	NR3C1 NR3C2	8.18e-06	2	100	2	17133261
Pubmed	Evaluation of steroid receptor function by gene targeting in mice.	NR3C1 NR3C2	8.18e-06	2	100	2	15860252
Pubmed	Glucocorticoid-dependent transcription in skin requires epidermal expression of the glucocorticoid receptor and is modulated by the mineralocorticoid receptor.	NR3C1 NR3C2	8.18e-06	2	100	2	33144612
Pubmed	Corticosterone suppresses the proliferation of BV2 microglia cells via glucocorticoid, but not mineralocorticoid receptor.	NR3C1 NR3C2	8.18e-06	2	100	2	22940619
Pubmed	Calpain-10 regulates actin dynamics by proteolysis of microtubule-associated protein 1B.	MAP1B CAPN10	8.18e-06	2	100	2	30425305
Pubmed	Genetic evidence for the association of the hypothalamic-pituitary-adrenal (HPA) axis with ADHD and methylphenidate treatment response.	NR3C1 NR3C2	8.18e-06	2	100	2	23055001
Pubmed	Comparative functional evolution of human and mouse CR1 and CR2.	CR1 CR2	8.18e-06	2	100	2	18713965
Pubmed	Pressure overload inhibits glucocorticoid receptor transcriptional activity in cardiomyocytes and promotes pathological cardiac hypertrophy.	NR3C1 NR3C2	8.18e-06	2	100	2	30946837
Pubmed	Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces.	NR3C1 NR3C2	8.18e-06	2	100	2	11154266
Pubmed	Interaction between the functional SNP rs2070951 in NR3C2 gene and high levels of plasma corticotropin-releasing hormone associates to postpartum depression.	NR3C1 NR3C2	8.18e-06	2	100	2	31388769
Pubmed	Acute deletion of the central MR/GR steroid receptor correlates with changes in LTP, auditory neural gain, and GC-A cGMP signaling.	NR3C1 NR3C2	8.18e-06	2	100	2	36873102
Pubmed	Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study.	CPB2 TAF1	8.18e-06	2	100	2	17327284
Pubmed	Suppression of intestinal neoplasia by deletion of Dnmt3b.	APC DNMT3B	8.18e-06	2	100	2	16581773
Pubmed	Complement receptor type 1 and 2 (CR1 and CR2) gene polymorphisms and plasma protein levels are associated with the Dengue disease severity.	CR1 CR2	8.18e-06	2	100	2	37833411
Pubmed	No associations between single nucleotide polymorphisms in corticoid receptor genes and heart rate and cortisol responses to a standardized social stress test in adolescents: the TRAILS study.	NR3C1 NR3C2	8.18e-06	2	100	2	20680430
Pubmed	Conditional Ablation of Glucocorticoid and Mineralocorticoid Receptors from Cochlear Supporting Cells Reveals Their Differential Roles for Hearing Sensitivity and Dynamics of Recovery from Noise-Induced Hearing Loss.	NR3C1 NR3C2	8.18e-06	2	100	2	36834731
Pubmed	CPEB3-dowregulated Nr3c1 mRNA translation confers resilience to developing posttraumatic stress disorder-like behavior in fear-conditioned mice.	CPEB3 NR3C1	8.18e-06	2	100	2	33941859
Pubmed	[THE COMBINATION OF EXPRESSION OF MARKERS CR1 AND CR2 (CD35/CD21) IN DIAGNOSTIC OF B-CELL LYMPHOPROLIFERATIVE DISEASES].	CR1 CR2	8.18e-06	2	100	2	26189291
Pubmed	Neonatal respiratory infection and adult re-infection: effect on glucocorticoid and mineralocorticoid receptors in the hippocampus in BALB/c mice.	NR3C1 NR3C2	8.18e-06	2	100	2	21440617
Pubmed	Corticosteroids and Regional Variations in Thickness of the Human Cerebral Cortex across the Lifespan.	NR3C1 NR3C2	8.18e-06	2	100	2	31240317
Pubmed	Direct Corticosteroid Modulation of GABAergic Neurons in the Anterior Hypothalamic Area of GAD65-eGFP Mice.	NR3C1 NR3C2	8.18e-06	2	100	2	21860595
Pubmed	Corticosteroid receptors adopt distinct cyclical transcriptional signatures.	NR3C1 NR3C2	8.18e-06	2	100	2	29733691
Pubmed	Malaria inhibits surface expression of complement receptor 1 in monocytes/macrophages, causing decreased immune complex internalization.	CR1 CR2	8.18e-06	2	100	2	23440418
Pubmed	USP10-mediated deubiquitination of NR3C1 regulates bone homeostasis by controlling CST3 expression.	NR3C1 USP10	8.18e-06	2	100	2	39236936
Pubmed	Interaction between tumor suppressor adenomatous polyposis coli and topoisomerase IIalpha: implication for the G2/M transition.	APC TOP2A	8.18e-06	2	100	2	18632987
Pubmed	Glucocorticoid receptor is indispensable for physiological responses to aldosterone in epithelial Na+ channel induction via the mineralocorticoid receptor in a human colonic cell line.	NR3C1 NR3C2	8.18e-06	2	100	2	21354648
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	CHL1 TNC CPB2 APOH GUSB CNTN3 C4BPA	9.89e-06	257	100	7	16335952
Pubmed	Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells.	TDP1 TOP2A	2.45e-05	3	100	2	22375014
Pubmed	Mineralocorticoid receptors dampen glucocorticoid receptor sensitivity to stress via regulation of FKBP5.	NR3C1 NR3C2	2.45e-05	3	100	2	34077736
Pubmed	TGFβ receptor endocytosis and Smad signaling require synaptojanin1, PI3K-C2α-, and INPP4B-mediated phosphoinositide conversions.	INPP4B PIK3C2A	2.45e-05	3	100	2	31913757
Pubmed	Molecular basis for glucocorticoid induction of the Kruppel-like factor 9 gene in hippocampal neurons.	NR3C1 NR3C2	2.45e-05	3	100	2	22962255
Pubmed	Glucocorticoid sensitivity in fibromyalgia patients: decreased expression of corticosteroid receptors and glucocorticoid-induced leucine zipper.	NR3C1 NR3C2	2.45e-05	3	100	2	18468809
Pubmed	Mineralocorticoid and glucocorticoid receptors stimulate epithelial sodium channel activity in a mouse model of Cushing syndrome.	NR3C1 NR3C2	2.45e-05	3	100	2	19635986
Pubmed	Frequency of the TAFI -438 G/A and factor XIIIA Val34Leu polymorphisms in patients with objectively proven pulmonary embolism.	CPB2 TAF1	2.45e-05	3	100	2	12958613
Pubmed	Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes.	CR1 CR2	2.45e-05	3	100	2	7690834
Pubmed	Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosis.	PCSK7 PNPLA3	2.45e-05	3	100	2	33565643
Pubmed	A complement receptor locus: genes encoding C3b/C4b receptor and C3d/Epstein-Barr virus receptor map to 1q32.	CR1 CR2	2.45e-05	3	100	2	3782802
Pubmed	Polymorphisms of genes related to the hypothalamic-pituitary-adrenal axis influence the cortisol awakening response as well as self-perceived stress.	NR3C1 NR3C2	2.45e-05	3	100	2	27427534
Pubmed	Murine complement receptor gene family. II. Identification and characterization of the murine homolog (Cr2) to human CR2 and its molecular linkage to Crry.	CR1 CR2	2.45e-05	3	100	2	2528587
Pubmed	Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interaction.	APC MTMR7	2.45e-05	3	100	2	38462034
Pubmed	Inhibition of intestinal tumor formation by deletion of the DNA methyltransferase 3a.	APC DNMT3B	2.45e-05	3	100	2	24837369
Pubmed	Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.	CR1 CR2	2.45e-05	3	100	2	7528766
Pubmed	Glucocorticoids induce gastroparesis in mice through depletion of l-arginine.	NR3C1 NR3C2	2.45e-05	3	100	2	25057793
Pubmed	Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors.	NR3C1 NR3C2	2.45e-05	3	100	2	21788604
Pubmed	Dysregulation of Hypothalamo-Pituitary-Adrenocortical Axis in Overweight Female Diabetic Subjects is Associated with Downregulation of Corticosteroid Receptors and 11β-HSD1 in the Brain.	NR3C1 NR3C2	2.45e-05	3	100	2	26212138
Pubmed	The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1.	CR1 CR2	2.45e-05	3	100	2	2139460
Pubmed	Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration.	NR3C1 NR3C2	2.45e-05	3	100	2	30664640
Pubmed	The manifold actions of the protein inhibitor of activated STAT proteins on the transcriptional activity of mineralocorticoid and glucocorticoid receptors in neural cells.	NR3C1 NR3C2	2.45e-05	3	100	2	15171715
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	UBE2K COL12A1 MAP1B APC PSMD5 CR2 RCC1L AFAP1L2 FGD5 FGD6	3.04e-05	689	100	10	36543142
Pubmed	Prediction of the coding sequences of unidentified human genes. XXI. The complete sequences of 60 new cDNA clones from brain which code for large proteins.	ITPRID2 CSMD3 TMEM132B AFAP1L2	3.36e-05	63	100	4	11572484
Pubmed	Identification of novel Ack1-interacting proteins and Ack1 phosphorylated sites in mouse brain by mass spectrometry.	MAP1B AFAP1 PPP1R18 CTNND2	4.29e-05	67	100	4	29254152
Pubmed	Yin Yang 1, Oct1, and NFAT-4 form repeating, cyclosporin-sensitive regulatory modules within the murine CD21 intronic control region.	CR2 NFATC3	4.89e-05	4	100	2	11907091
Pubmed	GRIP1-associated SET-domain methyltransferase in glucocorticoid receptor target gene expression.	NR3C1 GRIP1	4.89e-05	4	100	2	19074285
Pubmed	Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling.	APC KRIT1	4.89e-05	4	100	2	20007487
Pubmed	Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.	CR1 CR2	4.89e-05	4	100	2	16127466
Pubmed	The p23 molecular chaperones act at a late step in intracellular receptor action to differentially affect ligand efficacies.	NR3C1 NR3C2	4.89e-05	4	100	2	10691735
Pubmed	Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing.	APC DNMT3B	4.89e-05	4	100	2	18056424
Pubmed	Altered mRNA Levels of Glucocorticoid Receptor, Mineralocorticoid Receptor, and Co-Chaperones (FKBP5 and PTGES3) in the Middle Frontal Gyrus of Autism Spectrum Disorder Subjects.	NR3C1 NR3C2	4.89e-05	4	100	2	25912394
Pubmed	Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma.	CR1 CR2	4.89e-05	4	100	2	30217731
Pubmed	Development of the fetal intestine in mice lacking the glucocorticoid receptor (GR).	NR3C1 NR3C2	4.89e-05	4	100	2	12447992
Pubmed	Identification and characterization of HPA-axis reactivity endophenotypes in a cohort of female PTSD patients.	NR3C1 NR3C2	4.89e-05	4	100	2	25745955
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	FLNC OXR1 MAP1B TNC NUDT21 CORO1C APC IDH3A ITPR2 USP10 AFAP1 PPP1R18 KCNQ3 CTNND2	6.05e-05	1431	100	14	37142655
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	OXR1 MAP1B TNC CPEB3 APC PIK3C2A CTNND2	6.70e-05	347	100	7	17114649
Pubmed	Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress.	ACADM IDH3A NR3C1 TOP2A	7.79e-05	78	100	4	16236267
Pubmed	Ligand-specific glucocorticoid receptor activation in human platelets.	NR3C1 NR3C2	8.14e-05	5	100	2	16131566
Cytoband	1q32	CR1 CR2 C4BPA	1.72e-04	49	100	3	1q32
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	APOH CR1 CR2 CSMD3 C4BPA	3.32e-06	57	73	5	1179
GeneFamily	Fibronectin type III domain containing	CHL1 COL12A1 TNC PTPRO CNTN3 EPHA7	4.56e-05	160	73	6	555
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	CHL1 DIP2B MAP1B CPEB3 APC GRIA4 KMT2E CSMD3 TMEM132B CEMIP GRIP1 JAG2 NOL4L RUNDC3A PTPRO DCLK3 KCNQ3 CTNND2	1.82e-07	1106	100	18	M39071
Coexpression	GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP	RADX NR3C1 JMJD1C INPP4B SMAGP PCSK7 NR3C2 RIC3	9.10e-07	197	100	8	M5378
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	CHL1 OXR1 MAP1B MGAT4A HEMGN APC CPB2 APOH KMT2E INPP4B PTPRO CNTN3 CTNND2 EPHA7	1.30e-05	769	99	14	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	CUBN INPP4B GRIP1 SLC44A5 CNTN3 OCLN EPHA7	2.21e-07	187	100	7	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NEK10 INPP4B GRIP1 SLC44A5 CNTN3 CTNND2 EPHA7	2.94e-07	195	100	7	dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CHL1 CSMD3 AFAP1 AFAP1L2 SLC44A5 PTPRO CNTN3	3.48e-07	200	100	7	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CHL1 CSMD3 AFAP1 AFAP1L2 SLC44A5 PTPRO CNTN3	3.48e-07	200	100	7	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CHL1 CSMD3 AFAP1 AFAP1L2 SLC44A5 PTPRO CNTN3	3.48e-07	200	100	7	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CHL1 CSMD3 AFAP1 AFAP1L2 SLC44A5 PTPRO CNTN3	3.48e-07	200	100	7	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CHL1 CSMD3 AFAP1 AFAP1L2 SLC44A5 PTPRO CNTN3	3.48e-07	200	100	7	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CHL1 CSMD3 AFAP1 AFAP1L2 SLC44A5 PTPRO CNTN3	3.48e-07	200	100	7	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	Posterior_cortex-Neuronal-Inhibitory\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	GRIP1 AFAP1 SLC44A5 PTPRO MYO3B TUBE1	2.13e-06	167	100	6	9a84f45345c75f2c8ff38a04245aadee2a26a240
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TDRD9 APOH CR1 CSMD3 C4BPA CTNND2	3.74e-06	184	100	6	7ecdf2645e9378cf2f5ce4557f2cf100e6f184ba
ToppCell	droplet-Limb_Muscle-nan-3m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 CSMD3 AFAP1L2 DCLK3 PCYT2 PNPLA3	3.85e-06	185	100	6	554c5d812197fbf66bf279fcc953277e926ade15
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ARID4B OXR1 APC PIK3C2A NFATC3 TAF1	3.98e-06	186	100	6	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	GRIP1 SLC44A5 MYO3B NR3C2 CTNND2 OCLN	4.23e-06	188	100	6	0d86044bc340e3efb90d0022dd299873639d831c
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	GRIP1 MTMR7 SLC44A5 MYO3B CTNND2 OCLN	4.36e-06	189	100	6	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NEK10 GRIP1 SLC44A5 MYO3B CTNND2 OCLN	4.63e-06	191	100	6	60ff989fe99d243a3d52955223680cdd1f1917a4
ToppCell	Children_(3_yrs)-Epithelial-club_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	INPP4B GRIP1 SLC44A5 CNTN3 OCLN EPHA7	4.63e-06	191	100	6	23776c7302cead3881b39127398f3b3e0d27885e
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NEK10 GRIP1 SLC44A5 MYO3B CTNND2 OCLN	4.92e-06	193	100	6	b25cdca3a1e381784ae48ca73c51cbb6ac62b811
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NEK10 GRIP1 SLC44A5 MYO3B CTNND2 OCLN	5.06e-06	194	100	6	6b286992d4bb56013c0ea5a7601d3476d806175a
ToppCell	Control-B_memory-3\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MGAT4A CR1 SMAGP PCSK7 PPP1R18 FGD6	5.22e-06	195	100	6	135234f068da3e8db7213b53c09ed6d1d0cdc351
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CHL1 GRIP1 SLC44A5 MYO3B CTNND2 OCLN	5.22e-06	195	100	6	d673f8844896d5c7b76a7bc7f6b88a039f1bc263
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	INPP4B GRIP1 SLC44A5 CNTN3 OCLN EPHA7	5.69e-06	198	100	6	af399569c718f5fd971d73a7926768c9311002a3
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	OXR1 MAP1B CSMD3 TMEM132B GRIP1 KCNQ3	5.69e-06	198	100	6	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	INPP4B GRIP1 SLC44A5 CNTN3 OCLN EPHA7	5.69e-06	198	100	6	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	mLN-B_cell-B_cell_IgA_Plasma\|B_cell / Region, Cell class and subclass	TNC NUCB2 INPP4B AFAP1 MYO3B CTNND2	5.86e-06	199	100	6	09494953bc7fff63cf2763ea89fca7abb97c186f
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	DIP2B CPEB3 ITPR2 GRIP1 UBR3 NR3C2	5.86e-06	199	100	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	GRIP1 SLC44A5 PTPRO MYO3B TUBE1	2.63e-05	155	100	5	105d59d8a1bb8cb37eef2c1767d737b2108ac7c5
ToppCell	5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RPGRIP1 CR2 MYO3B FGD6 TOP2A	2.71e-05	156	100	5	203ef22eb76bd2b829b027c30af0557080f4006c
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-CLP\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NUCB2 HEMGN OAS2 SLFN13 DNMT3B	2.80e-05	157	100	5	d12f343454202da86a06d0369f8ffe5662cd091b
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	APC GRIA4 GRIP1 FGD5 MGRN1	3.16e-05	161	100	5	b81b346309f3facbfbebd91cae4c5b33c7bd24ef
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NEK10 HEMGN CUBN PCYT2 NR3C2	3.87e-05	168	100	5	9a8709d34865cfa668d8f3335dc34fc86fc32482
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HEMGN INPP4B TDP1 TUBE1 TOP2A	4.09e-05	170	100	5	2d5e56eee0c3ce75a9641cc14dee0e0807141c32
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 INPP4B AFAP1L2 DCLK3 CNTN3	4.32e-05	172	100	5	08a3fe536b1b064c5ee7779bc2b1115a5963a26b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 INPP4B AFAP1L2 DCLK3 CNTN3	4.32e-05	172	100	5	553701349444eb366df3c11f54bb093434f153c6
ToppCell	wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	FLNC GRIA4 AFAP1 PNPLA3 RIC3	4.45e-05	173	100	5	b43817a6b1ed8d6b5366702343be4311c0d52d83
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC GRIA4 CUBN CSMD3 MYO3B	4.45e-05	173	100	5	66f37c1437705734b20601656fa4aa1d92ca30be
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC GRIA4 CUBN CSMD3 MYO3B	4.45e-05	173	100	5	649b08a409095592cccf31883be69c754411280d
ToppCell	Adult-Epithelial-club_cell-D175\|Adult / Lineage, Cell type, age group and donor	GRIP1 SLC44A5 CNTN3 C4BPA OCLN	4.96e-05	177	100	5	d652b7d84fe6aa38319d8d5adc72c70441bd0088
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MGAT4A NUCB2 INPP4B AGBL3 NOL4L	5.09e-05	178	100	5	31c847d7f7aa0f6d820afbb45d507992f5e9dc2f
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	INPP4B GRIP1 SLC44A5 CNTN3 OCLN	5.37e-05	180	100	5	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 COL12A1 OXR1 SLC44A5 EPHA7	5.51e-05	181	100	5	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	INPP4B GRIP1 SLC44A5 CNTN3 OCLN	5.66e-05	182	100	5	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARID4B CR2 JMJD1C ZUP1 ITPR2	5.66e-05	182	100	5	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CR1 CR2 CEMIP JAG2 FGD5	5.66e-05	182	100	5	f231e86524b628e6e11ac33d5c34be99d454a92a
ToppCell	Adult-Epithelial-basal_cell\|Adult / Lineage, Cell type, age group and donor	CHL1 GRIP1 JAG2 CNTN3 EPHA7	5.80e-05	183	100	5	00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	ARID4B OAS2 NR3C1 JMJD1C FGD6	5.80e-05	183	100	5	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	OXR1 CUBN AGBL3 GRIP1 EPHA7	5.96e-05	184	100	5	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	OXR1 GRIA4 GRIP1 KCNQ3 EPHA7	6.27e-05	186	100	5	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	C10orf90 GRIP1 MYO3B NR3C2 CTNND2	6.43e-05	187	100	5	db2974e2e87ac9f1c2407a371d5ed89af09fc9b7
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HEMGN CPB2 APOH RUNDC3A C4BPA	6.43e-05	187	100	5	edb0ab0154542b1c0b3a2c216c4a60f0f06290b3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CPEB3 ITPRID2 INPP4B MYO3B NR3C2	6.59e-05	188	100	5	2ee64bc73a2251fd9f374be759b442cf4ed0d19e
ToppCell	3'-GW_trimst-2-LargeIntestine-Neuronal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 MAP1B C10orf90 TMEM132B AFAP1L2	6.59e-05	188	100	5	ccd2541892112a7a303f766adf9a7afeb754498c
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	GRIP1 SLC44A5 MYO3B CTNND2 OCLN	6.59e-05	188	100	5	beb2df2332a46cc81b10e8e29fc9829020111f03
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HEMGN CPB2 APOH RUNDC3A C4BPA	6.76e-05	189	100	5	7899af78b273d9c7f029d52f7e0cf6df4da41f5e
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	INPP4B GRIP1 SLC44A5 CNTN3 EPHA7	6.93e-05	190	100	5	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	OXR1 NEK10 MYO3B NR3C2 OCLN	6.93e-05	190	100	5	bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e
ToppCell	Non-neuronal-Postmitotic-Red_blood_cells-Low_Quality\|World / Primary Cells by Cluster	NACA HEMGN DCLK3 KCNQ3 RIC3	6.93e-05	190	100	5	31cf1367db5c04242621f7c98a10d094bc519e31
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	GRIP1 SLC44A5 MYO3B CTNND2 OCLN	6.93e-05	190	100	5	c95032bb3ee2b3d40fdf48016acb46d6f78a48a6
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HEMGN CPB2 APOH RUNDC3A C4BPA	6.93e-05	190	100	5	a34293601aefe5fb5c400c14091294b9ddaa195b
ToppCell	Non-neuronal-Postmitotic-Red_blood_cells\|World / Primary Cells by Cluster	NACA HEMGN DCLK3 KCNQ3 RIC3	6.93e-05	190	100	5	f0b82334375749d917e440c493f10340c52ea13c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	OXR1 NEK10 MYO3B NR3C2 OCLN	6.93e-05	190	100	5	b6b8964b4910083499681b5fdf554e127b6a4c4e
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 CSMD3 TMEM132B AFAP1L2 CNTN3	6.93e-05	190	100	5	6c7e1086c0a274cd5527c3104106e372811c9905
ToppCell	Non-neuronal-Postmitotic-Red_blood_cells-Low_Quality-14\|World / Primary Cells by Cluster	NACA HEMGN DCLK3 KCNQ3 RIC3	6.93e-05	190	100	5	feadd834d843f952aa7ced93899fd1f0868743df
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	OXR1 CPEB3 INPP4B MTMR7 MYO3B	6.93e-05	190	100	5	cc17ab84a9328124f146951c06be3eff9650d9fd
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NEK10 GRIP1 NOL4L MYO3B NR3C2	7.11e-05	191	100	5	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 OXR1 NEK10 MYO3B OCLN	7.11e-05	191	100	5	2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad
ToppCell	PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	GRIP1 SLC44A5 MYO3B CTNND2 OCLN	7.11e-05	191	100	5	63aa671837b79d2feb7ed1e67712cc01caf72bef
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 FRMD7 TMEM132B PTPRO CTNND2	7.11e-05	191	100	5	ece87127f85939e61b1048d968ed96f0e87c3a79
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 FRMD7 TMEM132B PTPRO CTNND2	7.11e-05	191	100	5	478e8341ee03b05501e2233e02cef5f97492c95d
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	GRIP1 MTMR7 SLC44A5 CTNND2 OCLN	7.28e-05	192	100	5	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	GRIP1 SLC44A5 MYO3B CTNND2 OCLN	7.46e-05	193	100	5	b38aaffbea36ef6c08ebe82675438f873c89b242
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	INPP4B GRIP1 SLC44A5 CNTN3 OCLN	7.46e-05	193	100	5	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NEK10 GRIP1 NOL4L MYO3B NR3C2	7.65e-05	194	100	5	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	PCW_13-14-Epithelial-Epithelial_airway\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	GRIP1 SLC44A5 MYO3B CTNND2 OCLN	7.65e-05	194	100	5	7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NEK10 GRIP1 NOL4L MYO3B NR3C2	7.65e-05	194	100	5	69bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell	PCW_07-8.5-Epithelial\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	GRIP1 MTMR7 SLC44A5 CTNND2 OCLN	7.65e-05	194	100	5	f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	GRIP1 SLC44A5 MYO3B CTNND2 OCLN	7.65e-05	194	100	5	f95c8dc242c9aebcadfe61b1ed033349cb7e5a88
ToppCell	severe-B_cell\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CHL1 ACADM APC CR2 PTPRO	7.83e-05	195	100	5	0fc3c605609c9e6bdea15d73c45def2188ae5fb1
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38\|World / Primary Cells by Cluster	ARID4B CORO1C NACA KMT2E KCNQ3	8.03e-05	196	100	5	38da0751941adca650fe9b383d9f343153978eb5
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41\|World / Primary Cells by Cluster	TDRD9 NUCB2 KMT2E NR3C2 RIC3	8.03e-05	196	100	5	dee0984cd63a1a2fdebb4421af48ab566a5b684e
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn\|World / Primary Cells by Cluster	ARID4B CORO1C NACA KMT2E KCNQ3	8.03e-05	196	100	5	721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37\|World / Primary Cells by Cluster	CHL1 TDRD9 NR3C2 CTNND2 RIC3	8.22e-05	197	100	5	00d756bc0231e1b3b88430214338c1059cb11106
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_T-T4_naive-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MGAT4A NACA NUCB2 INPP4B RIC3	8.22e-05	197	100	5	a0a2a0185b85b477e14fff5f9f6e4f5e2176bb49
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	ARID4B MGAT4A CR1 JMJD1C NFATC3	8.42e-05	198	100	5	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	Mild/Remission-B_memory-3\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MGAT4A CR1 SMAGP PPP1R18 FGD6	8.42e-05	198	100	5	44906dbf99ddd53335e2d32082ff7e77d91baaeb
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	OXR1 MAP1B CSMD3 TMEM132B SLC44A5	8.42e-05	198	100	5	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CHL1 CSMD3 GRIP1 SLFN13 EPHA7	8.42e-05	198	100	5	a54ae5275a510b49d7629f0908817a0c5f05020e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	OXR1 MAP1B CSMD3 SLC44A5 KCNQ3	8.42e-05	198	100	5	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CHL1 CSMD3 GRIP1 SLFN13 EPHA7	8.42e-05	198	100	5	34997e3896d0893fbe51bfb0d4660ccaca1c975e
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	ARID4B MGAT4A CR1 JMJD1C NFATC3	8.42e-05	198	100	5	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	PCW_10-12-Epithelial-Epithelial_airway\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	GRIP1 SLC44A5 MYO3B CTNND2 OCLN	8.42e-05	198	100	5	9a12e5e47236433e512c668005fe3f8be6fde95c
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Basal_2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CHL1 CSMD3 GRIP1 SLFN13 EPHA7	8.42e-05	198	100	5	686eda427b075e788de38149eae82faf19bd5704
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	ARID4B MGAT4A CR1 JMJD1C NFATC3	8.42e-05	198	100	5	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	OXR1 MAP1B CSMD3 GRIP1 KCNQ3	8.42e-05	198	100	5	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 MAP1B RUNDC3A KCNQ3 RIC3	8.62e-05	199	100	5	b4824d3683a4e3025b8e74a0f1755b331b2a0ba7
ToppCell	Caecum-(1)_T_cell-(16)_Tfh\|Caecum / shred on region, Cell_type, and subtype	HEMGN NR3C1 INPP4B KCNQ3 RIC3	8.62e-05	199	100	5	d07d77ae426dd1164d80d7031f14befa0369d3e5
ToppCell	Mild/Remission-B_memory-3\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MGAT4A CR1 SMAGP PPP1R18 FGD6	8.62e-05	199	100	5	493d043beef70b60338cc199db82592cdc6e635d
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CPEB3 CR1 PTPRO FGD6 TOP2A	8.62e-05	199	100	5	c6d59ed26eadd3c41acfe1b4d929270e00ea3e95
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6\|World / Primary Cells by Cluster	CHL1 NACA APC RIC3 EPHA7	8.62e-05	199	100	5	1b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 C10orf90 CSMD3 AFAP1L2 CNTN3	8.62e-05	199	100	5	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Caecum-T_cell-Tfh\|Caecum / Region, Cell class and subclass	HEMGN NR3C1 INPP4B KCNQ3 RIC3	8.62e-05	199	100	5	fb40f37d842f170ed101dfa3bffdb8f3b2c94f19
Drug	16 alpha-hydroxydehydroepiandrosterone	NR3C1 GUSB NR3C2	2.84e-06	7	100	3	CID000102030
Drug	mono-(2-ethylhexyl)phthalate	ZFAT COL12A1 TDRD9 MAP1B CUBN AGBL3 MTMR7 PCSK7 PPP1R18 CNTN3 TAF1 OCLN DNMT3B	6.17e-06	658	100	13	ctd:C016599
Drug	P-choline	APC PCSK7 CNTN3	1.32e-05	11	100	3	CID000124441
Drug	2-iminothiolane	TNC CPB2 NR3C1	1.76e-05	12	100	3	CID000433941
Drug	Flumethasone	NR3C1 NR3C2	1.91e-05	2	100	2	ctd:D005443
Drug	H-gpt-1	NR3C1 NR3C2	1.91e-05	2	100	2	CID000190908
Drug	prednylidene	NR3C1 NR3C2	1.91e-05	2	100	2	ctd:C036266
Drug	AC1L4S0Z	NR3C1 NR3C2	1.91e-05	2	100	2	CID000191181
Drug	Folic acid [59-30-3]; Down 200; 9uM; HL60; HG-U133A	RIPK1 NUCB2 IDH3A CR1 KRIT1 NFATC3 MGRN1	2.56e-05	196	100	7	1790_DN
Drug	LMWH	COL12A1 TNC MYH7B CPB2 ITPRID2 NR3C1 APOH PIK3C2A PCYT2 KCNQ3 C4BPA PNPLA3	3.41e-05	663	100	12	CID000000772
Drug	aldosterone-18-glucuronide	GUSB CNTN3 NR3C2	4.42e-05	16	100	3	CID000160706
Drug	nocodazole	RPGRIP1 MAP1B MYH7B APC KMT2E KRIT1 AFAP1 PTPRO MYO3B TUBE1	4.77e-05	477	100	10	CID000004122
Drug	Vincristine	ARID4B TDRD9 MGAT4A NACA ITPRID2 JMJD1C INPP4B AGBL3 NOL4L RCC1L SLC44A5 PIK3C2A PTPRO SLFN13 PCSK7 TOP2A	5.51e-05	1182	100	16	ctd:D014750
Drug	Alcohol, 8	NR3C1 NR3C2	5.71e-05	3	100	2	CID011213029
Drug	Methyl ether, 9	NR3C1 NR3C2	5.71e-05	3	100	2	CID011155441
Drug	secondary alcohol, 15	NR3C1 NR3C2	5.71e-05	3	100	2	CID011752649
Drug	Fludrocortisone	NR3C1 NR3C2	5.71e-05	3	100	2	DB00687
Drug	moxaverine	KRIT1 PCSK7	5.71e-05	3	100	2	CID000070881
Drug	Oxime, 22	NR3C1 NR3C2	5.71e-05	3	100	2	CID011282904
Drug	perphenazine enanthate	PIK3C2A GUSB	5.71e-05	3	100	2	CID000062871
Drug	tetrahydrocortisol	TNC NR3C1 GUSB NR3C2	5.88e-05	48	100	4	CID000005864
Drug	lecithin	TNC APOH PIK3C2A GUSB PCSK7 PCYT2 CNTN3 PNPLA3	6.06e-05	305	100	8	CID010425705
Drug	PKSI-527	CPB2 PIK3C2A GUSB	6.39e-05	18	100	3	CID000125291
Drug	nomegestrol	APOH PCYT2 NR3C2	7.57e-05	19	100	3	CID000068783
Disease	glutamine conjugate of C7H12O2 measurement	ACADM SLC44A5	1.05e-05	2	96	2	EFO_0800656
Disease	glutamine conjugate of C6H10O2 (2) measurement	ACADM SLC44A5	1.05e-05	2	96	2	EFO_0800658
Disease	acetylcarnitine-to-hexanoylcarnitine ratio	ACADM SLC44A5	1.05e-05	2	96	2	EFO_0021514
Disease	caproate 6:0 measurement	ACADM SLC44A5	1.05e-05	2	96	2	EFO_0021102
Disease	caprylate 8:0 measurement	ACADM SLC44A5	1.05e-05	2	96	2	EFO_0021103
Disease	Adenocarcinoma of large intestine	RIPK1 APC DCLK3 TAF1 EPHA7	1.59e-05	96	96	5	C1319315
Disease	Colorectal Carcinoma	CHL1 FLNC MAP1B APC CUBN CSMD3 CAPN10 NR3C2 CTNND2 RIC3 EPHA7	1.80e-05	702	96	11	C0009402
Disease	4-methylhexanoylglutamine measurement	ACADM SLC44A5	3.14e-05	3	96	2	EFO_0800576
Disease	(S)-3-hydroxybutyrylcarnitine measurement	ACADM SLC44A5	3.14e-05	3	96	2	EFO_0800475
Disease	hexanoylglutamine measurement	ACADM SLC44A5	6.26e-05	4	96	2	EFO_0800262
Disease	X-23680 measurement	ACADM SLC44A5	6.26e-05	4	96	2	EFO_0800862
Disease	type 2 diabetes mellitus (is_marker_for)	NUCB2 CPB2 APOH CAPN10 PIK3C2A	8.44e-05	136	96	5	DOID:9352 (is_marker_for)
Disease	Cis-4-decenoyl carnitine measurement	ACADM SLC44A5	1.04e-04	5	96	2	EFO_0022091
Disease	decenoylcarnitine measurement	ACADM SLC44A5	1.04e-04	5	96	2	EFO_0021803
Disease	suberoylcarnitine (C8-DC) measurement	ACADM SLC44A5	1.04e-04	5	96	2	EFO_0800382
Disease	Intellectual Disability	CHL1 OXR1 MAP1B APC KMT2E CAPN10 PCYT2 TAF1	1.08e-04	447	96	8	C3714756
Disease	schizophrenia (is_implicated_in)	CHL1 GRIA4 CTNND2 DNMT3B	1.25e-04	78	96	4	DOID:5419 (is_implicated_in)
Disease	nonanoylcarnitine (C9) measurement	ACADM SLC44A5	1.56e-04	6	96	2	EFO_0800381
Disease	pulse pressure measurement	DIP2B ZFAT MAP1B NEK10 NUCB2 ODF1 AFAP1 PIK3C2A UBR3 FGD5 CDK11B CTNND2 FGD6 DNMT3B	1.62e-04	1392	96	14	EFO_0005763
Disease	platelet component distribution width	UBE2K HEMGN CUBN JMJD1C INPP4B NOL4L AFAP1L2 C4BPA NR3C2 FGD6	1.76e-04	755	96	10	EFO_0007984
Disease	hexanoylglycine measurement	ACADM SLC44A5	2.18e-04	7	96	2	EFO_0800233
Disease	chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement	APOH JMJD1C PCSK7 PNPLA3	2.78e-04	96	96	4	EFO_0004530, EFO_0008317, EFO_0008596
Disease	binge eating	CUBN ARHGAP8	2.90e-04	8	96	2	EFO_0005924
Disease	Dickkopf-related protein 4 measurement	APOH JMJD1C	2.90e-04	8	96	2	EFO_0008110
Disease	cis-4-decenoylcarnitine (C10:1) measurement	ACADM SLC44A5	2.90e-04	8	96	2	EFO_0800311
Disease	octanoylcarnitine measurement	ACADM SLC44A5	3.72e-04	9	96	2	EFO_0021042
Disease	X-18921 measurement	ACADM SLC44A5	3.72e-04	9	96	2	EFO_0800796
Disease	cis-4-decenoate (10:1n6) measurement	ACADM SLC44A5	3.72e-04	9	96	2	EFO_0800318
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	APOH JMJD1C PNPLA3	4.58e-04	46	96	3	EFO_0008317, EFO_0008596, EFO_0020943
Disease	congenital left-sided heart lesions	MYH7B MGAT4A AFAP1L2	5.19e-04	48	96	3	EFO_0005938
Disease	X-21607 measurement	ACADM SLC44A5	5.65e-04	11	96	2	EFO_0800819
Disease	hexanoylcarnitine measurement	ACADM SLC44A5	6.77e-04	12	96	2	EFO_0021040
Disease	decanoylcarnitine measurement	ACADM SLC44A5	6.77e-04	12	96	2	EFO_0021039
Disease	Metastatic melanoma	NEK10 TAF1 EPHA7	7.34e-04	54	96	3	C0278883
Disease	glutaroyl carnitine measurement	ACADM SLC44A5	7.98e-04	13	96	2	EFO_0021005
Disease	cholesteryl esters to total lipids in large VLDL percentage	APOH JMJD1C PNPLA3	8.16e-04	56	96	3	EFO_0022250
Disease	trimethylamine-N-oxide measurement	CUBN ITPR2	9.29e-04	14	96	2	EFO_0010541
Disease	Global developmental delay	OXR1 KMT2E PCYT2 TAF1	9.51e-04	133	96	4	C0557874
Disease	cholesterol to total lipids in IDL percentage	JMJD1C PCSK7 PNPLA3	9.98e-04	60	96	3	EFO_0022233
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	APOH PCSK7 PNPLA3	1.05e-03	61	96	3	EFO_0008317, EFO_0008596, EFO_0020946
Disease	triglycerides to total lipids in chylomicrons and extremely large VLDL percentage	APOH PNPLA3	1.07e-03	15	96	2	EFO_0022328
Disease	platelet crit	DIP2B UBE2K ARID4B HEMGN CUBN APOH JMJD1C ITPR2 NOL4L PNPLA3	1.07e-03	952	96	10	EFO_0007985
Disease	Malignant neoplasm of liver	APC ZSCAN22 PTPRO TOP2A	1.21e-03	142	96	4	C0345904
Disease	Liver neoplasms	APC ZSCAN22 PTPRO TOP2A	1.21e-03	142	96	4	C0023903
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	JMJD1C PCSK7 PNPLA3	1.37e-03	67	96	3	EFO_0008595, EFO_0020946
Disease	venous thromboembolism, fibrinogen measurement	DIP2B JMJD1C C4BPA	1.37e-03	67	96	3	EFO_0004286, EFO_0004623
Disease	major depressive disorder (is_implicated_in)	NR3C1 CTNND2	1.38e-03	17	96	2	DOID:1470 (is_implicated_in)
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	APOH PNPLA3	1.38e-03	17	96	2	EFO_0022232
Disease	triglycerides to phosphoglycerides ratio	APOH JMJD1C PCSK7	1.43e-03	68	96	3	EFO_0022327
Disease	nephrotic syndrome (is_marker_for)	CPB2 NR3C1	1.55e-03	18	96	2	DOID:1184 (is_marker_for)
Disease	Autistic Disorder	APC KMT2E CSMD3 JMJD1C CNTN3	1.66e-03	261	96	5	C0004352
Disease	Pancreatic carcinoma	APC INPP4B	1.73e-03	19	96	2	C0235974
Disease	age at onset, smoking initiation	ITPR2 GRIP1	1.73e-03	19	96	2	EFO_0004847, EFO_0005670
Disease	free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	APOH PNPLA3	2.11e-03	21	96	2	EFO_0022277
Disease	cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage	APOH PNPLA3	2.11e-03	21	96	2	EFO_0022246
Disease	brain measurement, neuroimaging measurement	DIP2B CORO1C RGP1 JAG2 AFAP1 FGD6 DNMT3B	2.15e-03	550	96	7	EFO_0004346, EFO_0004464
Disease	Glioblastoma	APC JAG2 CTNND2	2.21e-03	79	96	3	C0017636
Disease	dilated cardiomyopathy (implicated_via_orthology)	FLNC MYH7B JAG2	2.29e-03	80	96	3	DOID:12930 (implicated_via_orthology)
Disease	Splenomegaly	APC OCLN	2.32e-03	22	96	2	C0038002
Disease	Schizophrenia	CHL1 APC GRIA4 NR3C1 APOH JAG2 KCNQ3 CTNND2 DNMT3B	2.35e-03	883	96	9	C0036341
Disease	urate measurement	NUDT21 ODF1 CUBN JMJD1C INPP4B CEMIP NFATC3 MYO3B PNPLA3	2.57e-03	895	96	9	EFO_0004531
Disease	Giant Cell Glioblastoma	APC JAG2 CTNND2	2.63e-03	84	96	3	C0334588
Disease	response to TNF antagonist, joint damage measurement	C10orf90 CSMD3	2.99e-03	25	96	2	EFO_0004653, EFO_0005413

Protein segments in the cluster

Peptide	Gene	Start	Entry
ETYPRPTKEDVYVVG	C4BPA	311	P04003
EPPYLTVGTDVSAKY	ARID4B	6	Q4LE39
TEPLYPDSKEATVVY	AGBL3	121	Q8NEM8
QTPYLSEETTYLEPG	CEP152	1636	O94986
PLKTFYEPGEEITYS	APOH	36	P02749
KYDYLEIEGSEPPTI	CSMD3	291	Q7Z407
TSDTGLEYEAPKLYP	DNMT3B	551	Q9UBC3
TSSLPEGYYEEAVPL	AFAP1	86	Q8N556
SPGKAPEYITSNYDS	AFAP1	101	Q8N556
QLAIPKTESPEGYYE	AFAP1L2	111	Q8N4X5
PFYDPDTSIIYLCGK	CORO1C	271	Q9ULV4
GTYKVVPSTYLPDTE	CAPN10	621	Q9HC96
EYGSPLKAYTPVVVT	CDK11B	586	P21127
IPVAAEYDKTGEYPV	ACADM	61	P11310
VDGSVSEYPGSYLTK	CEMIP	961	Q8WUJ3
LQYCPSVESPYSKSG	CTNND2	506	Q9UQB3
KTRGYEYVLEPSPVS	RCC1L	151	Q96I51
FYPESSYKSTPVPEV	OCLN	336	Q16625
VKDPTEYTGPESYVA	ITPR2	2601	Q14571
TVPKPPLYCYDVTIS	RADX	86	Q6NSI4
DTYTFTYPNITLKDP	OVOS1	131	Q6IE37
SSGLVEVISPPESYY	MGAT4A	201	Q9UM21
EPEIVYAGYDSSKPD	NR3C2	746	P08235
EKTTSPPEVSGYSYE	MAP1B	1961	P46821
PPEVSGYSYEKTERS	MAP1B	1966	P46821
LGDPSYSYETTEKIT	MAP1B	2001	P46821
TLYSGEDYPDTAPVI	CHL1	801	O00533
RVCDSYPTELYVPKS	MTMR7	156	Q9Y216
KEYQAKVTPTGPCSY	JAG2	76	Q9Y219
VTFPSEYPIYEETKI	INPP4B	96	O15327
PSAPLYEEITYSGIS	MGRN1	406	O60291
PRSYPSKEVSNIYGD	JMJD1C	1106	Q15652
EYYPTKGTSSPAEAE	KCNQ3	656	O43525
KQLTYTDVPYIPCTG	FRMD7	471	Q6ZUT3
TPTYVAPEILSEKGY	DCLK3	516	Q9C098
EYPGSETPPKYTSAL	GRIA4	286	P48058
ETPPKYTSALTYDGV	GRIA4	291	P48058
LYENYAGSCSTEPPK	MYH7B	666	A7E2Y1
SVPYLASYVSPVLKE	PCSK7	481	Q16549
PAAPYVTTLETLDKY	PCYT2	91	Q99447
YEPVPEGIYSEKVTD	NEK10	746	Q6ZWH5
TEDGADPNPYVKTYL	PIK3C2A	1586	O00443
PFYGEYDICPKVKST	PNPLA3	186	Q9NST1
ESAYTEPYKVCPISS	FGD5	841	Q6ZNL6
TPATDGPYTVAVKYA	FLNC	1506	Q14315
TITIKYGGDEIPYSP	FLNC	1611	Q14315
ISPAGTEPAYIEYKT	DIP2B	506	Q9P265
ETCRNGYKPIYSPVT	KMT2E	921	Q8IZD2
VVKDNTKYTYTPGCP	KRIT1	116	O00522
PEVLYAGYDSSVPDS	NR3C1	541	P04150
PEETYPIYDLSDCIK	RIC3	226	Q7Z5B4
KYGVKTTPESPPYSS	NOL4L	121	Q96MY1
PPYSSGSYDSIKTEV	NOL4L	131	Q96MY1
ESAKIEPPDTGLYYD	NUCB2	41	P80303
STPSPEVYAGLIDLY	OAS2	496	P29728
SLPPCVDEKDVTYSY	ODF1	176	Q14990
KFPGTKTYIDPETYE	EPHA7	601	Q15375
CSPPSFTYKYTPEEE	ITPRID2	766	P28290
PGSEKYSPETYQEIP	HEMGN	361	Q9BXL5
VTSVSIYDYKPSPET	PTPRO	121	Q16827
YVPDPEYVSSVESSP	OXR1	141	Q8N573
GIITSPKYPETYPSN	CUBN	2101	O60494
PCVSIEGYKTPYTDV	IDH3A	126	P50213
SYGSIVTYTCDPDPE	CR2	296	P20023
ETYCGLYPESEPEVK	CPB2	276	Q96IY4
PSGDIPYGKEISYTC	CR1	1336	P17927
VCYAGIDTDPELKYP	CPEB3	576	Q8NE35
TKYEVSVIPEYFSGP	COL12A1	786	Q99715
TGYILSYKPVKDTEP	COL12A1	1501	Q99715
DTPYTITVSSLYPDG	COL12A1	1816	Q99715
LPPGTIQYLTDTSKY	GUSB	181	P08236
VPVPEGYSVKCEYSA	C20orf27	96	Q9GZN8
SKAIGYVPSTLVYPA	SLC44A5	361	Q8NCS7
PLTNYTFGTKEPLYE	NUDT21	41	O43809
KPRSQTYPDVGLSYE	GRIP1	851	Q9Y3R0
YQYPSESSVLEELGP	PPP1R18	551	Q6NYC8
YPSYPDLVIDVGEVT	SLFN13	11	Q68D06
ESIVPYSPYEVKVGV	CNTN3	766	Q9P232
LDGKTPVVIDYTPYL	RUNDC3A	191	Q59EK9
KPYVSYLAPESEETP	MRPL41	71	Q8IXM3
YKFYDLPLSETETPV	RPGRIP1	1146	Q96KN7
YVTYEPTEGEPSAIV	SMAGP	66	Q0VAQ4
SVTPLDIYDPKDYSV	TMEM132B	711	Q14DG7
YIAVTDPLTYPTKFT	TAAR9	131	Q96RI9
LSSVTCIPGTTYKYP	TDRD9	116	Q8NDG6
DPGESKSYSYSEVLP	RGP1	106	Q92546
KSYSYSEVLPIEGPP	RGP1	111	Q92546
SNISYGSYEEPDPKS	TAF1	1796	P21675
VTDTLAKEGPSYPSY	CYB5R4	156	Q7L1T6
SLPPTDESIKYTIYN	RIPK1	521	Q13546
PIDYSLKYATDIPSS	APC	1176	P25054
YTTCPDVKVPYELIG	CIB3	46	Q96Q77
PDSIYYVDKSLSVPI	C10orf90	261	Q96M02
GKSSVPLYLIYPSVE	TDP1	431	Q9NUW8
PTDGCDYSTPDKYKL	ZFAT	801	Q9P243
SIYPSGEDDVITSPY	TUBE1	176	Q9UJT0
PYKSVTSLCAPEYEN	FGD6	736	Q6ZV73
IPGLKAATPYTVSIY	TNC	1131	P24821
YEGTCEIPESKYSPL	NFATC3	86	Q12968
VLAYAGYIPPSKEES	PHF23	41	Q9BUL5
EYYEKIFSTPEAPGE	ARHGAP8	406	P85298
TEPPYTYSGKRSSKC	ZSCAN22	256	P10073
GTEKTPPLITDYREY	TOP2A	946	P11388
VYAGAPVSSPEYTKK	UBE2K	151	P61086
EIKGSVYETTYSPPE	ZUP1	141	Q96AP4
TYPEDKLVYGVQEPS	UBR3	306	Q6ZT12
PVAYVETKYSPPAIS	USP10	356	Q14694
SEGPYYVKPVSTTAV	PSMD5	486	Q16401
SITSSYKYPEGSPEE	TGM7	441	Q96PF1
EYYKSLSPVDCIPEE	MYO3B	1306	Q8WXR4
ITKPDVYKSPASDTY	NACA	106	Q13765